Role of nuclear factor TOX in lymphocyte development
核因子 TOX 在淋巴细胞发育中的作用
基本信息
- 批准号:9751160
- 负责人:
- 金额:$ 43.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-12-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaBindingBinding ProteinsBiological ModelsBone MarrowCD4 Positive T LymphocytesCell Differentiation processCell Fate ControlCell LineageCellsChIP-seqChromatin Remodeling FactorCollectionCommon Lymphoid ProgenitorComplexDNA-Binding ProteinsDataDevelopmentDiseaseEpitopesEventGene ExpressionGene ProteinsGene TargetingGenesGenetic TranscriptionHBXAP geneHMG DomainHMG-BoxHMGB ProteinsIL2RA geneISWIImmuneImmune systemImmunityImmunoprecipitationIn VitroInnate Immune SystemKineticsKnockout MiceKnowledgeLeadLymphocyteLymphocyte SubsetLymphoid CellMass Spectrum AnalysisMediatingModelingMolecularMouse StrainsMusNatural Killer CellsNuclearPatternPlayPopulationProcessProteinsRegulationReporterResearch Project GrantsRoleSMARCA5 geneSignal TransductionStem cellsSystemT-Cell DevelopmentT-LymphocyteTestingThymocyte SelectionThymus GlandTissue-Specific Gene ExpressionUp-RegulationWorkcell typein vitro Modelin vivointerestmembernotch proteinnovelprecursor cellprogenitorsingle cell analysisthymocytetooltranscriptome
项目摘要
Project Summary/Abstract
Only recently has the extent of the diversity of innate immune effector functions become apparent, with
the discovery of multiple novel subtypes of innate lymphoid cells (ILCs), beyond long recognized natural
killer cells. ILCs derive from common lymphoid progenitors (CLP) in the bone marrow, and a number of
transcriptional regulators that are involved in ILC development also play roles in the development of T cells
in the thymus. Among these is TOX (thymocyte-selection associated HMG-box protein), a nuclear DNA
binding protein and member of the HMG-box superfamily of proteins.
Our previous work has shown that TOX is required for CD4 T cell lineage development in the thymus,
and for early ILC lineage specification. Using a TOX reporter strain of mouse we have now identified bone
marrow progenitor cells that may be in transition from CLP to the common progenitor to all helper-like innate
lymphoid cells (CHILP). CHILP highly express the transcriptional regulator Id2, but we have identified
Tox+Id2lo putative precursor cells, suggesting that upregulation of TOX likely precedes the formation of
CHILP. We propose to test the cell fate potential of these cells in vitro and in vivo, to determine what ILC
lineages they can form and if they have lost T cell potential. Similarly, we will ask if ILC lineage
specification even precedes Tox upregulation. Armed with this knowledge, we then propose to determine
the transcriptome in these cell types, at the single cell level, and to determine the influence of TOX on gene
expression. Notch signaling is also thought to play a role in early ILC lineage specification. We propose
that transient Notch signaling is key to distinguish ILC from T cell lineage commitment. Using an in vitro
model system that allows differentiation of CLP to multiple ILC subtypes, we will study the cell fate and
transcriptional consequences of a temporally limited Notch signal. As Tcf7 (encoding TCF-1), a key Notch
signaling target gene, is likely downstream of TOX, we ask if expression of Tcf7 can compensate for loss of
TOX. Finally, we address the underlying mechanism of action of TOX, using in vitro and in vivo approaches
to ask if TOX functions as part of a novel RSF ISWI chromatin-remodeling complex, and propose to
produce a novel mouse strain to aid in identification of gene targets and protein binding partners of TOX in
multiple cell contexts.
项目摘要/摘要
直到最近才使先天免疫效应子功能的多样性变得显而易见,并且
发现了先天淋巴样细胞(ILC)的多种新型亚型,超出了长期公认的天然
杀手细胞。 ILC源自骨髓中常见的淋巴祖细胞(CLP),许多
参与ILC开发的转录调节剂也在T细胞的发展中起作用
在胸腺中。其中包括毒物(胸腺丝体相关的HMG-box蛋白),一种核DNA
结合蛋白和蛋白质HMG-box超家族的成员。
我们以前的工作表明,胸腺中CD4 T细胞谱系的发育需要托克斯,
以及早期的ILC谱系规范。使用小鼠的托克斯报道菌株我们现在已经鉴定出骨头
骨髓祖细胞可能从CLP过渡到公共祖细胞到所有辅助型先天性
淋巴样细胞(CHILP)。高度表达转录调节剂ID2,但我们已经确定了
TOX+ID2LO推定的前体细胞,表明TOX的上调可能是在形成之前
辣椒。我们建议在体外和体内测试这些细胞的细胞命运潜力,以确定什么ILC
它们可以形成谱系,如果它们失去了T细胞电位。同样,我们会询问ILC血统是否
规格甚至先于托克斯上调。凭借这些知识,我们建议确定
这些细胞类型的转录组,在单细胞水平上,并确定毒物对基因的影响
表达。 Notch信号传导还被认为在早期ILC谱系规范中起作用。我们建议
该瞬态Notch信号传导是区分ILC和T细胞谱系承诺的关键。使用体外
允许将CLP分化为多个ILC亚型的模型系统,我们将研究细胞命运和
时间限制的Notch信号的转录后果。作为TCF7(编码TCF-1),键缺口
信号靶基因可能是托克斯的下游,我们询问TCF7的表达是否可以补偿
毒品。最后,我们使用体外和体内方法解决了托克斯的基本作用机理
询问托克斯是否作为新型RSF ISWI染色质复制复合物的一部分,并提议
产生一种新的小鼠菌株,以帮助鉴定托克斯的基因靶标和蛋白质结合伴侣
多个单元环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN G KAYE其他文献
JONATHAN G KAYE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN G KAYE', 18)}}的其他基金
Regulation of Treg activity by controlling FOXP3 expression
通过控制 FOXP3 表达来调节 Treg 活性
- 批准号:
9373172 - 财政年份:2017
- 资助金额:
$ 43.75万 - 项目类别:
A novel small molecule probe to study TOX-family transcriptional regulators
一种用于研究 TOX 家族转录调节因子的新型小分子探针
- 批准号:
9324512 - 财政年份:2017
- 资助金额:
$ 43.75万 - 项目类别:
Structure/Function Analysis of TOX, a Key Regulator of NK Cell Development
NK 细胞发育的关键调节因子 TOX 的结构/功能分析
- 批准号:
8702947 - 财政年份:2014
- 资助金额:
$ 43.75万 - 项目类别:
Role of Nuclear Factor TOX in Germinal Center Reactions
核因子 TOX 在生发中心反应中的作用
- 批准号:
7790233 - 财政年份:2008
- 资助金额:
$ 43.75万 - 项目类别:
Role of Nuclear Factor TOX in Germinal Center Reactions
核因子 TOX 在生发中心反应中的作用
- 批准号:
7446924 - 财政年份:2008
- 资助金额:
$ 43.75万 - 项目类别:
Role of Nuclear Factor TOX in Germinal Center Reactions
核因子 TOX 在生发中心反应中的作用
- 批准号:
7687579 - 财政年份:2008
- 资助金额:
$ 43.75万 - 项目类别:
TOX, a Novel Regulator of Thymocyte Selection
TOX,胸腺细胞选择的新型调节剂
- 批准号:
7319650 - 财政年份:2003
- 资助金额:
$ 43.75万 - 项目类别:
TOX, a Novel Regulator of Thymocyte Selection
TOX,胸腺细胞选择的新型调节剂
- 批准号:
6983411 - 财政年份:2003
- 资助金额:
$ 43.75万 - 项目类别:
TOX, A Novel Regulator of Thymocyte Selection
TOX,胸腺细胞选择的新型调节剂
- 批准号:
8037783 - 财政年份:2003
- 资助金额:
$ 43.75万 - 项目类别:
TOX, a Novel Regulator of Thymocyte Selection
TOX,胸腺细胞选择的新型调节剂
- 批准号:
6828313 - 财政年份:2003
- 资助金额:
$ 43.75万 - 项目类别:
相似国自然基金
定向金属结合区域的倒捻子素类PDE4抑制剂:类药性优化及抗肺纤维化作用研究
- 批准号:22277019
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
定向金属结合区域的倒捻子素类PDE4抑制剂:类药性优化及抗肺纤维化作用研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
高光谱遥感与地面观测数据结合的区域甘蔗糖分估算研究
- 批准号:42105175
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ERβ结合区域遗传变异与结直肠癌发病风险的机制研究
- 批准号:
- 批准年份:2020
- 资助金额:57 万元
- 项目类别:面上项目
基于“区域资源高效协同机制”作用的医养结合养老社区中医疗功能空间配置研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别:
Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
阐明艾滋病毒和大麻素暴露期间神经源性大脑区域的单细胞变化
- 批准号:
10686685 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别:
Cytoskeleton-mediated regulation of insulin secretion hot spots in pancreatic beta cells
细胞骨架介导的胰腺β细胞胰岛素分泌热点的调节
- 批准号:
10679903 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别:
Protein Phosphorylation Networks in Health and Disease
健康和疾病中的蛋白质磷酸化网络
- 批准号:
10682983 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 43.75万 - 项目类别: